Richard Drachtman
Pediatric Hematology-Oncology · New Brunswick, NJNPI 1609958248
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $202,080 of the $271,094 with a category attached, or 74.5%. 20 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 42.4% of the total. Reporting peaked in 2022 at $67,306 and has fallen 61.1% since, to $26,210 in 2025. Among pediatric hematology-oncology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $1071.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$115K
- Pfizer$53K
- Jazz Pharmaceuticals Inc.$44K
- Agios Pharmaceuticals, Inc.$21K
- Novartis$11K
- Chiesi USA, Inc.$6K
- plus $20K from 14 others
Across 185 payments — averaging $5611.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$542K
- Global Blood Therapeutics, Inc.$125K
- Pfizer$111K
- Merck$94K
- Novartis$66K
- Incyte Corporation$59K
- plus $42K from 2 others
What the payments were for
- Consulting fees$47,61118%
- Speaking & faculty fees$202,08075%
- Travel & lodging$14,6505%
- Food & beverage$6,6722%
- Education$810%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 71 | $115,030 |
| Pfizer | 45 | $53,042 |
| Jazz Pharmaceuticals Inc. | 36 | $44,195 |
| Agios Pharmaceuticals, Inc. | 26 | $21,463 |
| Novartis | 20 | $11,170 |
| Chiesi USA, Inc. | 18 | $6,254 |
| E.r. Squibb & Sons, L.L.C. | 2 | $4,233 |
| Apo-pharma Inc. | 2 | $3,780 |
| Merck | 16 | $2,947 |
| Day One Biopharmaceuticals | 1 | $2,600 |
| Servier Pharmaceuticals LLC | 2 | $2,550 |
| Bayer | 1 | $1,541 |
| Seagen Inc. | 1 | $1,100 |
| Sanofi | 2 | $750 |
| Sobi, Inc | 4 | $129 |
| Genetix Biotherapeutics Inc | 1 | $128 |
| Amgen | 1 | $85 |
| RARE Disease Therapeutics, Inc. | 2 | $46 |
| Fennec Pharmaceuticals, Inc. | 1 | $30 |
| Vertex | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$271,094 in reported general payments places this provider in the 95th percentile of 54 pediatric hematology-oncology providers in New Jersey.
See all pediatric hematology-oncology providers in New Jersey →
Other pediatric hematology-oncology in New Brunswick
- Niketa ShahNew Brunswick$29K
- Scott MoerdlerNew Brunswick$11K
- Peter ColeNew Brunswick$678
- Jocelyn LewisNew Brunswick$596
- Marissa BotwinickNew Brunswick$489
- Susan MurphyNew Brunswick$386
- Nibal ZaghloulNew Brunswick$333
- Christeen AzmyNew Brunswick$225
- Morgan PinesNew Brunswick$187
- Archana SharmaNew Brunswick$153
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.